Patent · US Active

Piperazine substituted bridged spiro[2.4]heptane derivatives as ALX receptor agonists

US9533964B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

Actelion Pharmaceuticals Ltd. · CH

Inventors

Olivier Corminboeuf · Allschwil, CH
Sylvaine Cren · Allschwil, CH
Davide Pozzi · Allschwil, CH

Key dates

Filing date	Jul 17, 2014
Grant date	Jan 3, 2017
Priority date	—
Expiry date	Jul 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D295/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a piperazine substituted bridged spiro[2.4]heptane derivative of formula (I),its preparation and its use as pharmaceutically active compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.